Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Results of the two incidence screenings in the National Lung Screening Trial.

Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team..

N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962.

2.

Reduced lung-cancer mortality with low-dose computed tomographic screening.

National Lung Screening Trial Research Team., Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD.

N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.

3.

Identification of chemically diverse, novel inhibitors of 17β-hydroxysteroid dehydrogenase type 3 and 5 by pharmacophore-based virtual screening.

Schuster D, Kowalik D, Kirchmair J, Laggner C, Markt P, Aebischer-Gumy C, Ströhle F, Möller G, Wolber G, Wilckens T, Langer T, Odermatt A, Adamski J.

J Steroid Biochem Mol Biol. 2011 May;125(1-2):148-61. doi: 10.1016/j.jsbmb.2011.01.016. Epub 2011 Feb 12.

PMID:
21300150
4.

The National Lung Screening Trial: overview and study design.

National Lung Screening Trial Research Team., Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ.

Radiology. 2011 Jan;258(1):243-53. doi: 10.1148/radiol.10091808. Epub 2010 Nov 2.

5.

Species used for drug testing reveal different inhibition susceptibility for 17beta-hydroxysteroid dehydrogenase type 1.

Möller G, Husen B, Kowalik D, Hirvelä L, Plewczynski D, Rychlewski L, Messinger J, Thole H, Adamski J.

PLoS One. 2010 Jun 8;5(6):e10969. doi: 10.1371/journal.pone.0010969.

6.

[Cross-reactive carbohydrate determinants in diagnostics of occupational allergy].

Zgorzelska-Kowalik J, Wiszniewska M, Kowalik D, Krawczyk-Szulc P, Nowakowska-Swirta E, Pałczyński C, Walusiak-Skorupa J.

Med Pr. 2010;61(1):79-89. Review. Polish.

PMID:
20437891
7.

Structure-based design, synthesis and in vitro characterization of potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone.

Möller G, Deluca D, Gege C, Rosinus A, Kowalik D, Peters O, Droescher P, Elger W, Adamski J, Hillisch A.

Bioorg Med Chem Lett. 2009 Dec 1;19(23):6740-4. doi: 10.1016/j.bmcl.2009.09.113. Epub 2009 Oct 3.

PMID:
19836949
8.

In search for function of two human orphan SDR enzymes: hydroxysteroid dehydrogenase like 2 (HSDL2) and short-chain dehydrogenase/reductase-orphan (SDR-O).

Kowalik D, Haller F, Adamski J, Moeller G.

J Steroid Biochem Mol Biol. 2009 Nov;117(4-5):117-24. doi: 10.1016/j.jsbmb.2009.08.001. Epub 2009 Aug 22.

PMID:
19703561
9.

Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.

Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV.

Nature. 2000 Aug 31;406(6799):959-64.

PMID:
10984043
10.

Depression and marital interaction: concordance between intent and perception of communication.

Kowalik DL, Gotlib IH.

J Abnorm Psychol. 1987 May;96(2):127-34. No abstract available.

PMID:
3584661

Supplemental Content

Loading ...
Support Center